2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

2016 Texas Life Science Forum 2016 Texas Life Science Forum Note: There are great discounts for early registration and for being or becoming a member of BioHouston and/or the Rice Alliance. To inquire about membership, please visit: Thursday, May 26, 2016 8:00 am - 6:30 pm BioHouston BioScience Research Collaborative (BRC) Rice Alliance 6500 Main Street

Houston, Texas 77030 Registration Refund/Cancellation Policy: General Registrations are 100% refundable through May 11, 2016. (713) 632-4130 Refunds are 50% refundable from May 12 through May 18. There are no refunds after May 18.

Company Registration Policy: Company presentation registrations are non-refundable after May 7, 2016.

Who's Attending? CONFIRMED INVESTORS AND Agenda Speakers Presenting Past Investors INDUSTRY LEADERS Companies Sponsorship FAQs Opportunities

Testimonials Hotels

Presenting Sponsor

Gold Underwriters

One on One Meeting Sponsors

Welcome Reception Sponsor

Networking Reception and Company Showcase Sponsor

Company Presentation Sponsor

http://alliance.rice.edu/2016_txlsvf/[12/15/2016 10:33:02 AM] 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

General Sponsors

Exhibiting Sponsors

Supporting Sponsors

Venture Patrons

http://alliance.rice.edu/2016_txlsvf/[12/15/2016 10:33:02 AM] 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Quick Facts Recent Speakers Company Spotlight Earned Excellence

2011 #14 Best U.S. Graduate Entrepreneurship Program – US News & World Report

Janice and Robert McNair Hall Jesse H. Jones Graduate School of Business © Copyright 2014 P.O. Box 2932-MS 531 George R. Brown School of Engineering Rice Alliance for Technology and Entrepreneurship Houston, Texas 77252-2932 Wiess School of Natural Sciences Rice University

http://alliance.rice.edu/2016_txlsvf/[12/15/2016 10:33:02 AM] Agenda - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

2016 Venture Forum Agenda 2016 Texas Life Science Forum MAY 26, 2016 - THURSDAY Thursday, May 26, 2016 8:00 am - 6:30 pm 7:30 – 8:30 AM Registration and Networking Breakfast BioScience Research Collaborative (BRC) Location: Exhibit Hall, 6500 Main Street Lobby Houston, Texas 77030 (713) 632-4130 8:30 – 9:00 AM Transforming the Texas Life Sciences Landscape: There is no “I” in “Team” Location: Auditorium Erik Halvorsen, Ph.D., Director, Innovation Institute, TMCx

9:00 – 9:30 AM Biotech in 2016: A Capital Markets Update Location: Auditorium Nate Chang, Credit Suisse Securities, Investment Banking & Capital Markets, Global Health Agenda Speakers 9:30 – 10:00 AM VC and Corporate VC Panel Presenting Past Investors Location: Auditorium Matthew Cohen, Ph.D., Osage University Partners Companies Stephen Curtis, Ph.D., 2M Companies, Inc. Sponsorship FAQs Aaron Royston, M.D., venBio Partners LLC Opportunities David Schubert, Accelerator Corporation (Moderator) Armen Shanafelt, Ph.D., Lilly Ventures Testimonials Hotels

10:00 – 10:20 AM Networking Break

10:20 – 10:50 AM Startup Resources in Texas Location: Auditorium Erin Flores, Ph.D., Business Analyst, TMC Innovation Institute Presenting Sponsor Mellie Price, Executive Director of Technology Innovation, Dell Medical School John Reale, Managing Director, Station Houston Emmanuelle Schuler, Ph.D., JLABS Angela Shah, Editor, Xconomy Texas (Moderator) Cindy WalkerPeach, Ph.D., Director, Health/Biosciences, Austin Technology Incubator Gold Underwriters in the IC2 Institute, UT Austin

10:50 – 11:00 AM Update From DeBakey Award Winner – OrthoAccel Technologies Location: Auditorium Michael Lowe, CEO One on One Meeting Sponsors Lexicon Pharmaceuticals 11:00 – 11:10 AM Jeffrey Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Location: Auditorium CFO

11:10 – 11:20 AM Mirna Therapeutics Welcome Reception Sponsor Location: Auditorium Paul Lammers, M.D., M.Sc., President & CEO

11:20 – 11:30 AM ESSA Pharma Location: Auditorium David Parkinson, M.D., President, CEO & Director Networking Reception and 11:30 – 11:40 AM Bellicum Pharmaceuticals Company Showcase Sponsor Location: Auditorium Alan Musso, CPA, CFA, CFO and Treasurer

11:40 – 11:50 AM Aeglea Biotherapeutics Location: Auditorium David Lowe, Ph.D., Co-Founder, President & CEO Company Presentation Sponsor

http://alliance.rice.edu/2016_txlsvf_agenda/[12/15/2016 10:40:54 AM] Agenda - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Texas Leading NIH Initiative to Enhance Reproduction and Transparency of 11:55 – 12:00 PM Research Findings Location: Auditorium William Buras, Senior Director, Life Sciences, Tietronix Software

12:00 – 1:00 PM Networking Lunch General Sponsors Location: Exhibit Hall

COMPANY PRESENTATIONS:

1:00 – 4:45 PM 1:00 PM Castle Biosciences, Inc. 2:59 PM Meds Report Exhibiting Sponsors Location: Auditorium 1:04 PM IntuiTap Medical 3:03 PM VisionSR 1:09 PM Simergent, LLC 3:08 PM Entvantage Diagnostics, Inc. 1:13 PM Cell Systems-3D, LLC 3:12 PM Cognita Labs, LLC 1:18 PM Immatics 3:17 PM Noninvasix 1:22 PM Aprenda Systems 3:22 PM Stem Cell Reserve 1:27 PM Inscope Medical Solutions 3:26 PM Agilvax 1:32 PM Click It Clinic 3:31 PM Beta Cat Pharmaceuticals, Inc. 1:36 PM CorInnova, Inc. 3:35 PM Acera Surgical, Inc. 1:41 PM Macromoltek 3:40 PM Saranas 1:45 PM Pulmotect, Inc. 3:45 PM Minimus Spine, Inc.

1:50 PM JET Lasik 3:49 PM Lung Therapeutics, Inc. 1:55 PM Oncolix, Inc. 3:54 PM MolecularMatch, Inc. 1:59 PM ENTRx, LLC 3:58 PM NovaScan, LLC Supporting Sponsors 2:04 PM Valera Health 4:03 PM Fabre-Kramer Pharmaceuticals 2:08 PM MedeStat, Inc. 4:07 PM StemMed, Ltd. 2:13 PM Innovator Health 4:12 PM Adhesys Medical 2:17 PM Vyripharm 4:17 PM DiFusion, Inc. 2:22 PM BreviTest Technology 4:21 PM Decisio Health 2:27 PM Stream Biomedical, Inc. 4:26 PM LETO Solutions, Inc. 2:31 PM DNAtrix 4:30 PM Medicenna Therapeutics, Inc. 2:36 PM CAVU Biotherapies, Inc. 4:35 PM Curtana Pharmaceuticals, Inc. 2:40 PM C4 Imaging, LLC 4:40 PM Will 2 Love, LLC 2:45 PM Gravitas Medical, Inc. 4:44 PM Formation Biologics 2:50 PM Northworks Automation 4:49 PM Prospiria, Inc. 2:54 PM Tuevol Therapeutics, Inc. 4:53 PM Mu Therapeutics

5:00 – 5:05 PM TMCx Demo Day Preview Location: Auditorium 5:00 CareSet Systems 5:01 DocResponse 5:02 GreenLight Medical 5:03 The RIght Place

EDUCATIONAL SYMPOSIA

1:00 – 1:30 PM Project, Product or Company? Market and Competitive Analysis Location: Room 280 Imran Alibhai, Ph.D., DNAtrix Jim Graham, Strike Bio, Inc.

1:00 – 1:30 PM Attracting Big Pharma & Negotiating Partnerships: Do’s and Don’ts Location: Room 1003 Erin Thomson, Vinson & Elkins LLP

1:30 – 2:00 PM Fast-Tracking Clinical Trials and Research via Cloud Computing Location: Room 280 Ayman Husain, Slalom Consulting Mike Kuo, FACHE, Slalom Consulting

1:30 – 2:00 PM Everything Rises or Falls With Leadership Venture Patrons Location: Room 1003 Joanne Mitchell, Ph.D., John Maxwell Team

2:00 – 2:30 PM Developing a Successful SBIR/STTR Application – Think Like a Reviewer! Location: Room 280 Jacob Setterbo, Ph.D., HIRETech Margaret Boulware, J.D., Boulware & Valoir (Moderator)

2:00 – 2:30 PM Life Science Startup Resources and Programs Provided by the Region’s Location: Room 1003 Institutions Bruce Butler, Ph.D., UT Health Larry Hope, M.D. Anderson Cancer Center LauraLee Hughes, Texas A&M Health Science Center Kala Marathi, University of Houston Andrew Wooten, Baylor College of Medicine

2:30 – 3:00 PM Networking Break

http://alliance.rice.edu/2016_txlsvf_agenda/[12/15/2016 10:40:54 AM] Agenda - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

3:00 – 3:30 PM 510K Labeling Requirement and General Regulatory for Medtech Location: Room 280 Carmelina Allis, J.D., The Allis Law Firm, PLLC

3:30 – 4:00 PM Accounting 101 For Start-Ups & The New R&D Tax Credit Location: Room 280 Chris Hatten, CPA, PKF Texas Sam Razmandi, CPA,PKF Texas Patrick Samuels, CPA, PKF Texas

4:00 – 4:30 PM Intellectual Property Protection Strategies for Companies Location: Room 280 Mini Kapoor, Ph.D., J.D., Haynes & Boone LLP John Demarco, J.D., Haynes & Boone LLP Frank Amini, Ph.D., Winstead PC Chuck Landrum, Ph.D.,J.D., Norton Rose Fulbright LLP

4:30 – 5:00 PM IP 101: Is Your Invention Patentable? Location: Room 280 Tamsen Valoir, Ph.D., J.D., Boulware & Valoir

5:05 PM AWARDS PRESENTATION Location: Auditorium

Most Promising Life Science Companies Award Brad Burke, Rice Alliance for Technology and Entrepreneurship

Michael E. DeBakey Life Science Award Ann Tanabe, BioHouston

5:15- 6:30 PM RECEPTION AND COMPANY SHOWCASE Location: Exhibit Hall

Quick Facts Recent Speakers Company Spotlight Earned Excellence

The most recent Rice Alliance Company Directory included more than 500 companies, the largest ever collection of new technology companies in the region

http://alliance.rice.edu/2016_txlsvf_agenda/[12/15/2016 10:40:54 AM] Presenting Companies - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Presenting Companies 2016 Texas Life Science Forum If you would like to apply to present at this year’s Texas Life Science Forum, please click here. Thursday, May 26, 2016 8:00 am - 6:30 pm Acera Surgical, Inc. BioScience Research Collaborative (BRC) http://www.acera-surgical.com 6500 Main Street Nanofabricated surgical materials poised to disrupt existing biologics Houston, Texas 77030 (713) 632-4130

Adhesys Medical http://www.adhesys-medical.com We are developing next generation surgical adhesives based on polyurethane, for use in unprecedented areas of surgery. Agenda Speakers

Presenting Past Investors Companies BetaCat Pharma, Inc. Sponsorship FAQs http://www.betacatpharma.com Opportunities

Testimonials Hotels Agilvax http://www.agilvax.com Agilvax develops cancer immunotherapies, with a focus on cancer stem cell targets, and vaccines utilizing a proprietary virus-like particle (VLP) discovery and development platform technology. Presenting Sponsor BreviTest Technology http://www.brevitest.com BreviTest is developing a rapid testing device for law enforcement, physicians, and others who require portable immunodiagnostic solutions. Gold Underwriters

C4 Imaging LLC http://www.c4imaging.com Implantable medical devices that utilize a unique, encapsulated MRI contrast agent to One on One Meeting Sponsors improve care and enhance outcomes in patients diagnosed with a wide range of cancers.

Castle Biosciences Welcome Reception Sponsor http://www.castlebiosciences.com We develop DecisionDx molecular tests that provide tumor-specific information for better decision-making and patient care.

Networking Reception and Company Showcase Sponsor

CAVU Biotherapies, Inc CAVU Biotherapies is an early stage translational onco-biotech company focused on providing immune-based solutions to treat cancer and autoimmune diseases Company Presentation Sponsor in pet dogs.

http://alliance.rice.edu/2016_txlsvf_presenting_companies/[12/15/2016 10:41:20 AM] Presenting Companies - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

General Sponsors

Cell Systems-3D, LLC http://www.cellsystems3d.com Providing 3-D microtissue models using human, veterinary and insect cells for early drug development efficacy and toxicity evaluations. Exhibiting Sponsors

click it clinic http://www.clickitclinic.com Empower physicians to provide the best care ONLINE

Cognita Labs, LLC http://www.cognitalabs.com Cognita Labs is developing next generation of diagnostic and medication adherence devices for respiratory healthcare. Supporting Sponsors

CorInnova, Inc. http://www.corinnova.com CorInnova is a medical device company developing a non-blood contacting biventricular cardiac assist device to treat end stage heart failure (HF) that is substantially less invasive than existing devices, expanding the market by three to four times.

Curtana Pharmaceuticals, Inc. http://www.curtanapharma.com Curtana Pharmaceuticals is developing the first truly targeted small molecule therapeutics for the treatment of glioblastoma and other brain cancers.

DiFusion Inc http://www.difusiontech.com Maker of SMART Surgical Polymers

DNAtrix http://www.dnatrix.com DNAtrix is a clinical stage immuno-oncology company developing first-in-class, virus-driven (“oncolytic”) technology platforms designed to trigger tumor cell death and elicit durable immune responses against cancer.

ENTRx, LLC http://www.eargold.com ENTRx has developed a single dose, physician administered treatment for bacterial and fungal otitis externa

Entvantage Diagnostics, Inc. Venture Patrons http://www.entv-dx.com Entvantage Diagnostics is developing point-of-care rapid tests to assist physicians in knowing when to prescribe antibiotics to patients with common illnesses such as sinusitis.

Fabre-Kramer Pharmaceuticals, Inc. http://www.fabrekramer.com Develops psychotropic drugs to address major unmet medical needs.

Formation Biologics http://www.formationbiologics.com Treatment of cancer with immunotherapeutics and immunoconjugates

Gravitas Medical, Inc. http://www.gravitasmedinc.com Gravitas Medical, Inc is developing a novel nasogastric (NG) feeding system to improve patient health outcomes, reduce cost-of-care, and reduce nursing burden in device placement and residual volume measurements.

Immatics http://www.immatics.com

Innovator Health http://www.innovatorhealth.com Innovator Health improves underserved populations' access to high quality medical care through a digital teleportation hardware platform, emphasizing the importance of the provider/patient interaction and relationship.

Inscope

JET Lasik JET Lasik’s proprietary collagen-coated contact lens with a layer of live cultured skin cells, will improve both the safety and recovery time of corneal wound healing, allowing the device to act as a post-operative tissue transplant “bandage” in photorefractive keratectomy (PRK).

LETO Solutions, Inc. http://www.LetoSolutions.net Leto Solutions, Inc. develops innovative medical devices that provide targeted temperature management to improve comfort, provide neuroprotection, and enhance quality of life.

Lung Therapeutics, Inc. http://www.lungtx.com Lung Therapeutics leverages validated drug programs to develop first in class therapies for unmet needs in lung injury and disease.

Macromoltek https://www.macromoltek.com/ Macromoltek is building software to help companies understand their drug targets andreduce failures in clinical trials.

MedeStat, Inc http://www.medestat.com Our portable solutions allow medical personnel to access patient information without the need for Internet access.

Medicenna Therapeutics, Inc. http://www.medicenna.com We are an immuno-oncology company that specifically targets cancer cells expressing IL-4; IL-2 or IL-13 receptors and deliver a cell killing toxin as a payload to initiate tumor death.

Minimus Spine, Inc. http://www.minimusspine.com We offer patients a non-surgical treatment for a painful spinal disc herniation.

MolecularMatch, Inc. http://www.molecularmatch.com

We have developed a first in kind platform for laboratories to interpret molecular diagnostic tests using our matching software.

Mu Therapeutics Broad Spectrum Vaccine for Heroin and Opiod Addiction

Noninvasix www.noninvasix.com Noninvasive monitoring of cerebral oxygenation in the neonatal intensive care unit.

Northworks Automation www.northworks3d.com Finally a fast, reliable 3D printer designed specifically for production environments.

NovaScan LLC http://www.novascanllc.com NovaScan instantaneously detects the presence of cancer, either in vivo or ex vivo with unmatched accuracy and without capital equipment.

Oncolix, Inc. http://www.oncolixbio.com Company is focused on gynecological cancers with a new drug with a novel mechanism of action.

OregonHeart, Inc. OregonHeart is developing a next generation Total Artificial Heart.

Pulmotect, Inc. http://www.pulmotect.com

Boosting the innate immune system in the lungs to prevent and treat respiratory infections.

Saranas http://www.saranas.com Saranas is a Houston based medical device company enabling rapid detection of internal bleeding complications in vascular access procedures.

Simergent, LLC http://www.scienceinman.com

Simergent is developing an automated peritoneal dialysis device and disposable tubing set intended for emerging market countries.

Stem Cell Reserve http://www.stemcellreserve.com

Stem Cell Reserve is revolutionizing the umbilical cord banking industry through its patented family or public stem cell and biomatrix banking service and umbilical cord derived biotechnology products.

StemMed, Ltd. http://www.stemmedcancer.com StemMed is a drug discover, development, and testing company.

Stream Biomedical, Inc. Stream Biomedical is commercializing a recombinant protein to address unmet therapeutic needs for individuals suffering as a result of neurologic trauma and/or degeneration.

Teomcis http://www.teomics.com Teomics is a Houston-based companion diagnostic company shortening the path to personalized medicine by unlocking the power of protein biomarkers.

Tuevol Therapeutics, Inc. http://www.tuevol.com Tuevol Therapeutics is developing novel cancer therapies capitalizing on the tumor cell microenvironment.

VisionSR http://www.visionsr.com VisionSR produces a structured reporting solution for diagnostic imaging that is like Facebook for medicine in that it captures keys images, tags them with metadata, and assembles an interactive multimedia report.

Will 2 Love, LLC http://www.will2love.com Will 2 Love provides online education and help for cancer-related problems with sexuality or fertility.

Quick Facts Recent Speakers Company Spotlight Earned Excellence

Houston’s Greatest Economic Development Ally – Awarded by the Greater Houston Partnership – 2008

http://alliance.rice.edu/2016_txlsvf_presenting_companies/[12/15/2016 10:41:20 AM] FAQs - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Frequently Asked Questions (FAQs) 2016 Texas Life Science Forum

Thursday, May 26, 2016 Q: Who are the primary contact people if I have any additional questions? 8:00 am - 6:30 pm Contacts: BioScience Research Collaborative (BRC) · Sam Mason – Rice Alliance – [email protected] – (713) 632-4130 6500 Main Street · Elizabeth Wellington – BioHouston – [email protected] – (713) 979-9106 Houston, Texas 77030

(713) 632-4130 Q: What is the Texas Life Science Forum? The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. Co-produced by BioHouston and the Rice Alliance for Technology & Entrepreneurship, the Forum showcases life science companies and provides for networking opportunities with investors, big pharma, and others. This annual event is an opportunity for you to highlight promising life science technologies and companies in a venue that on average attracts more than 500 venture capitalists, investors, academics, successful entrepreneurs, and other business leaders. Agenda Speakers Q: Where do I find more information about Forum co-producers BioHouston & Rice Alliance? Presenting Past Investors · BioHouston: www.biohouston.org Companies · Rice Alliance: www.alliance.rice.edu Sponsorship FAQs Opportunities Q: When and where does the Texas Life Science Forum take place? Date: Thursday, May 26, 2016 (8:00am-6:00pm Central Time) Testimonials Hotels Location: BioScience Research Collaborative (BRC) Rice University Campus (adjacent to the Texas Medical Center) 6500 Main Street (corner of University Drive) Houston, TX 77030 713-348-8600 (Security Desk) Map: http://brc.rice.edu/content.aspx?id=35 *** See below for driving directions *** Presenting Sponsor

Q: What is the audience profile? Members of the audience include investors, venture capitalists, industry representatives, business leaders, advisors/mentors, service providers, entrepreneurs, and the students, faculty and staff of various academic institutions. Gold Underwriters

Q: How many people attend the Texas Life Science Forum? The average attendance in recent years is around 550 people.

Q: What is the dress code? The dress code for the Forum is Business or Business Casual. One on One Meeting Sponsors

Q: What about overnight lodging? For convenient lodging options, visit: http://explore.rice.edu/explore/Hotel.asp

Q: What if I need a taxi? Welcome Reception Sponsor Yellow Cab offers a service that can be ordered in advance or by calling (713) 236-1111. Estimated fares from local airports are as follows:

Bush Intercontinental Airport (IAH) is about a 45-minute ride and costs about $65.00 plus tip Hobby Airport (HOU) is about a 25-minute ride and costs about $40.00 plus tip Networking Reception and When placing an order for either drop-off or pick-up, please use the following address: Company Showcase Sponsor

BioScience Research Collaborative (BRC) 6500 Main Street (at the corner of University Drive) Houston, TX 77030 Company Presentation Sponsor Q: If I drive, where do I park on campus?

http://alliance.rice.edu/2016_txlsvf_faqs/[12/15/2016 10:41:50 AM] FAQs - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

The most convenient parking lot is beneath the BRC building. The fee for parking in this garage is $1.00 for each 12 minutes, with an $11.00 daily maximum. ** There are no in-and-out privileges for this garage. ** Also note: we expect the garage will fill up; in order to ensure you have a parking space, we recommend you arrive by 8:00 am.

General Sponsors Q: How do I get to the BRC?

Directions to the BRC Garage (Rice Parking Office: 713.348.2020)

From Bush Intercontinental Airport (IAH) 1. From IAH’s Terminal Road, follow signs to US 59 South. Exhibiting Sponsors 2. Proceed south on US 59 approximately 25 miles and exit at Greenbriar. 3. Turn left under US 59 and follow Greenbriar south. 4. Head south on Greenbriar until you reach University Dr. 5. Turn left onto University Dr. 6. Turn right onto Main St. then another right onto Dryden. 7. BRC garage entrance will be on your right.

From Hobby Airport (HOU) 1. From Hobby Airport, exit onto Broadway and follow signs to I-45 N.

2. Proceed north on I-45 approximately 6 miles to US 59 South. 3. Proceed south on US 59 approximately 3 miles and exit at Greenbriar. 4. Head south on Greenbriar until you reach University Dr. 5. Turn left onto University Dr. 6. Turn right onto Main St. then another right onto Dryden. 7. BRC garage entrance will be on your right. Supporting Sponsors

From I-45 north or south 1. Proceed north or south on I-45 and follow the signs to US 59 south. 2. From US 59 south on US 59 and exit at Greenbriar / Shepard.

3. Head south on Greenbriar until you reach University Dr. 4. Turn left onto University Dr. 5. Turn right onto Main St. then another right onto Dryden. 6. BRC garage entrance will be on your right.

From US-59 north or south 1. Proceed north or south on US 59 and exit at Greenbriar / Shepard. 2. Head south on Greenbriar until you reach University Dr. 3. Turn left onto University Dr. 4. Turn right onto Main St. then another right onto Dryden. 5. BRC garage entrance will be on your right.

From downtown Houston 1. Proceed south on Fannin Street until you reach Sunset Blvd. 2. Turn right onto Sunset Blvd, then left onto Main St. 3. Turn right onto Main St. then another right onto Dryden. 4. BRC garage entrance will be on your right.

Venture Patrons

http://alliance.rice.edu/2016_txlsvf_faqs/[12/15/2016 10:41:50 AM] FAQs - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Quick Facts Recent Speakers Company Spotlight Earned Excellence

National Model MBA in Entrepreneurship—United States Association for Small Business and Entrepreneurship (USASBE) - 2011

http://alliance.rice.edu/2016_txlsvf_faqs/[12/15/2016 10:41:50 AM] Testimonials - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Testimonials 2016 Texas Life Science Forum Comments from Attendees at the 2015 Texas Life Science Forum Thursday, May 26, 2016 8:00 am - 6:30 pm “Coming from an academic lab, I was impressed by the innovative ideas by a lot of the attendees. BioScience Research Collaborative (BRC) In addition, I saw that biotech is quite active in the Houston area.” 6500 Main Street Houston, Texas 77030 “Great attendance!” (713) 632-4130

“I was impressed with the quality of people who attended the event and their willingness to share knowledge and mentor young scientists as myself.”

“I was introduced to investors and other entrepreneurs from the Houston area -- many of which I never would have met organically following my own personal network.”

Agenda Speakers “The overall symposium was very helpful to me. The networking was good. Everyone was quite communicative.” Presenting Past Investors Companies “The quality of the people attending from all areas of biotech - academia, industry, financial.” “Well Sponsorship FAQs done.” Opportunities

“Best networking ever, good crowd.” Testimonials Hotels

“General organization and amenities were great.”

“Great Meeting this year!!!”

Presenting Sponsor “I am now a lot smarter!”

“I received a much better understanding of the life science landscape in Texas, at the start-up and small business level. I also had good networking experiences.” Gold Underwriters “I think the flow of the program worked well..”

“I think the overall structure of the event was planned perfectly. It gave everyone the opportunity to discuss their business but also to network with industry colleagues.”

“Location/logistics worked extremely well; excellent program and roster of guest speakers” One on One Meeting Sponsors

“Very well organized, and lots of positive connections.”

“While the auditorium was great, there weren't enough seats for all attendees.” Welcome Reception Sponsor “1:1 meetings were excellent”

“I enjoyed the educational tract; I was able to tailor my afternoon to my career interests.”

“I liked all the choices.” Networking Reception and “I really enjoyed having multiple tracks in the afternoon to attend sessions that I found particularly Company Showcase Sponsor interesting.”

“I thought the plenary speakers and topics were excellent.”

“Networking was one of the most valuable opportunities provided by the forum.” Company Presentation Sponsor

http://alliance.rice.edu/2016_txlsvf_testimonials/[12/15/2016 10:42:14 AM] Testimonials - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

“Speakers I saw were well prepared and knew their topics.”

“The educational symposium topics were great- I often had trouble choosing which one to attend.” General Sponsors “Candid conversations about how to truly grow sustainable companies.”

“Fantastic forum.”

“Gained new insight on IP and startups.” Exhibiting Sponsors “This was my first time attending this meeting, but I really liked the content and format of the presentations. The panelists were excellent. The location was very good for the size of the meeting.”

“I was extremely happy to be involved and to have attended/participated; I would be happy to do so again.”

“Opening sessions good. Company presentations excellent as always.”.

“Outstanding location.”

“Great event; I thoroughly enjoyed my time and the opportunity for my students.”

“Great, as usual!” Supporting Sponsors “I look forward to this every year. It is one of the most important local events to me. Thanks for hosting.”

“If I had known how good TLSF would have been, I would have suggested it to more of my colleagues.”

“Outstanding place to meet the Texas scientific community, especially industry.”

“We need Texas to look better than California.”

“As a first timer, I enjoyed interacting with industry leaders and learned a great deal about collaboration opportunities in the med center.”

“There were not enough room in the rooms.”

Venture Patrons

http://alliance.rice.edu/2016_txlsvf_testimonials/[12/15/2016 10:42:14 AM] Testimonials - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Quick Facts Recent Speakers Company Spotlight Earned Excellence

More than 120 past teams have launched their companies and are in business today having raised more than $337 million in funding.

http://alliance.rice.edu/2016_txlsvf_testimonials/[12/15/2016 10:42:14 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

2016 Speakers 2016 Texas Life Science Forum Aaron Royston, M.D. Thursday, May 26, 2016 8:00 am - 6:30 pm BioScience Research Collaborative (BRC) Dr. Royston joined venBio with experience in life science venture capital, healthcare 6500 Main Street strategy, and entrepreneurship. Dr. Royston received his undergraduate degree from Houston, Texas 77030 Duke University, his M.D. and M.B.A. degrees from the University of Pennsylvania, and (713) 632-4130 coordinated clinical research at Mount Sinai Medical Center, where his research has been published and presented in multiple medical journals and conferences. Dr. Royston has prior experience in life science venture capital with Vivo Capital, and previously worked at Bain & Company, where he advised healthcare companies on strategic issues such as business model innovation and therapeutic area strategies.

In 2009, Dr. Royston developed and launched a technology platform in the health and fitness space, for which he was selected as a recipient of the Champion of Change Award Agenda Speakers in Technology and Innovation from the United States White House. Presenting Past Investors Companies Alan Musso Sponsorship FAQs CFO and Treasurer, Bellicum Pharmaceuticals Opportunities

Testimonials Hotels Alan Musso joined Bellicum in November 2014 and serves as Chief Financial Officer and Treasurer. He has over 25 years of biotech and pharmaceutical industry experience in both large and emerging growth companies, including capital raising, corporate partnering, finance, strategy and the financial stewardship of publicly-traded companies. He most recently served as Senior Vice President, Finance and Administration, CFO and Treasurer of Targacept, Inc. He began his career working in the public accounting field at Presenting Sponsor KPMG and later held positions of increasing responsibility with Pfizer. Mr. Musso received a B.S. in Accounting from Saint Mary’s College of California, and a master’s degree from the American Graduate School of International Management in Glendale, Arizona.

Imran Alibhai, Ph.D. Gold Underwriters Managing Director, DNAtrix

Imran Alibhai has extensive investment and advisory experience in the healthcare public and private equity markets. He leads the Houston office of DNAtrix. Prior to DNAtrix, he was an investment banker in Peter J. Solomon Company’s Healthcare Advisory Group, One on One Meeting Sponsors focused on M&A transactions in science based markets including biopharmaceuticals, medical devices/diagnostics and life science tools. Previously, he was the Senior Director at Alexandria Venture Investments, where he was responsible for investments in emerging companies and funds in the healthcare sector. He also directed investments for PIPE’s and long/short positions in MPM Capital’s BioEquities hedge fund. Imran began his career in early stage venture capital at the Accelerator Corp., where he was involved Welcome Reception Sponsor in every facet of company/project formation and management. Imran holds a PhD in Molecular Neuroscience from the University of Texas Southwestern Medical School and a BS in Biology from Duke University.

Andrew Wooten, MST, MTM Networking Reception and Executive Director, Research Business Development & Strategy; Founding Executive Company Showcase Sponsor Director, Innovation Development Center, Baylor College of Medicine

Andrew joined Baylor College of Medicine in 2012. He is leading Baylor’s integrated innovation development and entrepreneurship strategy. Andrew is creating strategies to facilitate the translation of Baylor’s biomedical innovation assets into real-world products, Company Presentation Sponsor ventures and jobs. This includes building support programs and infrastructure. It also

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

includes attracting stakeholders and commercial partners to support these efforts. As a result of this activity Baylor was successful in obtaining U.S. Economic Development Administration funding to help build the new Innovation Development Center (IDC). The IDC facility has laboratories, office space, conference rooms, cubicles and other infrastructure for supporting innovation and entrepreneurship. IDC will serve as home for General Sponsors the commercialization track of Baylor’s new team-focused training and educational initiative.

Prior to joining Baylor Andrew held a variety of positions at the interface of academia and industry. Former positions include: Director of Outreach and Commercialization with Exhibiting Sponsors Gateway University Research Park; Vice President, U.S. West with Neri Capital Partners; Vice President & Managing Director of Health Science Ventures with Arizona Technology Enterprises; Life Science Project Manager, Office of Technology & Intellectual Property, University of Chicago; President, Ovo Biosciences; Director of Corporate Development & Strategic Planning, Avigenics/Alexion; and Genetic Analysis Representative, Business Development, Applied Biosystems/Thermo Fisher Scientific. Andrew has a B.A in Chemistry from Berea College, a Master’s of Science Technology with a concentration in Biotechnology from the University of Georgia and a Master’s in Technology Management with a concentration in Finance from Mercer University.

Armen Shanafelt, Ph.D. General Partner, Lilly Ventures

Armen Shanafelt brings over 24 years of experience in the pharmaceutical, biotechnology, and diagnostic businesses to Lilly Ventures. Previous to joining Lilly Supporting Sponsors Ventures, Armen was CSO responsible for the generation of the early biotherapeutic pipeline for Eli Lilly and Company, spanning the therapeutic areas of oncology, endocrine, and neuroscience. During his 7 years with Lilly, the biotherapeutic group delivered over 20 molecules into clinic development.

Ayman Husain

Ayman is the Practice Area Lead for the Houston Market focused on Cloud and Infrastructure Practice. As the lead of his practice, Ayman is a client facing cloud strategist and technical consultant with proven and hands-on experience. He develops innovative solutions to solve business and technology challenges by leveraging Microsoft & AWS cloud solutions. He is also an expert on core infrastructure platforms with expert level capability in datacenter, identity management, messaging, collaboration, cloud and end-user computing. Ayman is a seasoned Technical Project Manager and has hands-on experience with all stages of cloud and infrastructure solutions, including requirements definition, design, architecture, and implementation. He is adept at executive and C-level presentations and workshops to create adoption strategies and roadmaps.

Bruce Butler

Dr. Bruce D. Butler is Vice President Research and Technology, and directs the Office of Technology Management at the University of Texas Health Science Center at Houston (UTHealth). The office handles the technology transfer activities including the creation of new start-ups for the six UTHealth schools and the UTHealth faculty at the Texas Heart Institute. Dr. Butler also holds an academic position as Professor in the Department of Anesthesiology at the Medical School and managed a research program in collaboration with NASA, U.S. Navy and several international pharmaceutical companies. He has over 200 published papers, abstracts and book chapters. Other positions he holds include VP for the Office of Global Health Initiatives, Associate Director of the UTHealth / MD Anderson Cancer Center-Center for Advanced Biomedical Imaging Research (CABIR). Dr. Butler is an inventor on numerous U.S. and associated foreign patents; several of which have been commercialized through UTHealth that include respiratory healthcare products and bio-pharmaceuticals. He has been involved with product development for medical and home-care devices, including FDA regulatory approvals and clinical trials. Dr. Butler has been personally involved in the creation of 5 life-science start-ups and numerous other business development partnerships. Venture Patrons

Carmelina G. Allis, Esq.

Ms. Allis is an attorney with over 20 years of experience on matters related to the U.S. Food and Drug Administration (FDA) regulation of medical devices. She has experience on a wide range of regulatory matters, including medical device approval/clearance, product jurisdiction, device classification, pre-clinical/bench studies, human clinical trials, postmarket compliance, mobile apps, labeling, promotion, and advertising. Her device

experience crosses all medical specialties. Ms. Allis is a former engineer reviewer at the Office of Device Evaluation (ODE) in FDA's Center for Devices and Radiological Health (CDRH), which is the body responsible for the approval and clearance of new medical devices entering the U.S. market. She is also a former Assistant Chief Counsel for Enforcement at FDA's Office of the Chief Counsel. Ms. Allis has a private practice in Houston, Texas, specializing in helping both start-up and established companies throughout all stages of the FDA medical device regulatory process.

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Chris Hatten

Chris has approximately 15 years of public accounting experience. His experience includes audit and financial consulting for publicly owned and privately held businesses. Areas of industry concentration include power generation, oilfield service, midstream energy, internet based services, hospitality, manufacturing and software development companies.

His SEC reporting experience includes reporting on Form 10K and Form 10Q. He is also in-charge of the firms SSAE 16 engagements and has experience with SOX 404 engagements.

He provides audit and financial reporting services to clients with international operations including U.S. and foreign-owned companies with multiple subsidiaries and locations.

Chuck Landrum

Chuck Landrum's extensive scientific background and legal experience help inventors prepare, protect and fully explore their patents' commercial applications. As a patent attorney his patent prosecution experience includes appellate briefs, interference practice, patent preparation and patent prosecution.

Chuck has drafted provisional and non-provisional patent applications in various fields, including immunodiagnostics, DNA sequencing, vaccines, protein folding algorithms, herbal therapeutics, DNA microarray analysis, chemical processes, and medical devices.

As patent attorney, Chuck understands complex technologies and communicates effectively with academic experts as well as technology transfer teams. He frequently counsels universities, scientists and inventors.

David Lowe, Ph.D. CEO, Aeglea BioTherapeutics

David G. Lowe PhD has been a research scientist managing and leading drug discovery programs, a venture capitalist investing in emerging and mid stage life science companies, and most recently a biotechnology entrepreneur. He joined Genentech in 1985 as post-doctoral fellow and ultimately became a Senior Scientist in Molecular Biology and later Director of Cardiovascular Research. At Genentech, David led drug discovery activities in biologics and small molecule therapeutics, and was a member of the therapeutic area team responsible for strategic planning and product portfolio management. He was responsible for drug discovery efforts that resulted in eight drugs that moved into clinical trials, including the successful cancer therapy Avastin®. He also worked extensively with Genentech’s Business Development group on in-licensing of early and late-stage therapeutics, and technology access. In 2002 David joined Palo Alto CA based Skyline Ventures to apply his expertise to healthcare venture capital. As a Managing Director at Skyline David had positive returns, leading investments in companies developing new therapeutics and research tools. Starting in late 2012 David became CEO of Aeglea BioTherapeutics, an Austin TX based start-up company. Aeglea is developing new biologic therapies for oncology that originated from Prof. Georgiou’s laboratory at the University of Texas at Austin. David holds B.S. and Ph.D. degrees in biochemistry from the University of Toronto, Canada. He has authored over 60 peer- reviewed scientific publications and is an inventor of seven issued U.S. patents.

David M. Schubert CEO, Accelerator Corporation

David M. Schubert is Chief Operating Officer of Accelerator Corporation, a biotechnology focused venture capital backed investment vehicle located in New York City and Seattle, Washington.

From May of 2012- August of 2014, Mr. Schubert served as Executive Director of the Houston Area Translational Research Consortium (HATRC) at Rice University, a biotechnology-based non-for-profit organization that focused on filling the gap between R&D investment and translation of discovery to the clinic in the form of marketable products to treat diseases. While at HATRC Mr. Schubert was a Venture Partner at Accelerator.

From 2005 to May of 2012, Mr. Schubert served as the President and Chief Business Officer of Accelerator. Prior to Accelerator, in 2001 Mr. Schubert spun CellExSys Corporation out of Targeted Genetics Corporation (where he led Business Development and Investor Relations from 1997-2001), and then successfully led the acquisition of CellExSys by Chromos Molecular Systems (Vancouver, BC). Mr. Schubert began his career in 1993 at Baxter Healthcare Corporation where he served in various roles in strategic planning, sales and marketing in both Europe and the United States.

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Mr. Schubert holds an MBA degree with concentrations in Marketing and Management from Pennsylvania State University, an M.S. in Biology with a concentration in Immunology from Utah State University and a BS in Biology and a BA in Psychology from Eastern Nazarene College (Quincy, Massachusetts). Mr. Schubert serves as member of the Board of Directors of The National Marrow Donor Program (NMDP) and Enventure (Houston, Texas).

Emmanuelle Schuler

Emmanuelle Schuler is the Head of JLABS @TMC, Johnson & Johnson’s latest life science incubator. Emmanuelle’s focus is on bringing together executives, investors, entrepreneurs, thought leaders, clinicians and inventors to create innovative solutions that impact patients’ life and healthcare delivery. She collaborates with J&J Innovation and J&J’s corporate venture capital group to attract companies in alignment with their strategic efforts in biopharma, diagnostics, medical de¬vices and consumer healthcare.

Dr. Schuler brings over ten years of experience in intellectual capital management, strate¬gic alliances, and joint ventures. Prior to joining J&J, she led IP-based transactions at MD Anderson Cancer Center. Before that, she was responsible for industry-based strategic collaborations at the University of Houston. She consulted with the European Commis¬sion on innovation policy issues. She also worked on science policy projects under the mentorship of Nobel Laureate Dr. Richard E. Smalley at Rice University. Emmanuelle founded an award-winning Science Café in Copenhagen and another in Houston where she led public debates at the intersection of science, art and culture.

Emmanuelle earned a Bachelor of Science degree in chemistry from Université du Québec à Montréal, a Ph.D. in chemistry from McGill University, and a Master of Business Administration degree from Rice University.

Erin Ator Thomson

Erin's principal areas of practice are strategic intellectual property counseling, technology transactions (including patent, trademark, copyright, and trade secret licensing), and intellectual property litigation, primarily in the areas of pharmaceuticals, biotechnology, research tools, medical devices, consumer products, and software. She has extensive experience assisting clients in evaluating, structuring, and negotiating intellectual property and technology transactions, and conducting due diligence associated with such transactions. Erin also has experience in all stages of patent litigation, including conducting pre-suit investigations, drafting and arguing motions, taking and defending depositions, preparing for and conducting Markman hearings, and trial. She also conducts due diligence evaluations and has experience prosecuting patents for life sciences- related inventions.

Erin received a J.D. summa cum laude from Baylor Law School and a B.S. in Biology from Pepperdine University. Prior to law school, she spent time as a post-graduate researcher at The University of California – San Francisco. Prior to joining Vinson & Elkins, she served as a judicial clerk for The Honorable Chief Justice Wallace Jefferson of the Supreme Court of Texas.

Erin has been selected to Super Lawyers’ Texas Rising Stars list since 2012. She is also a member of the Intellectual Property Owners Association (in which she is secretary of the Licensing Committee), the Licensing Executive Society, the Austin IP Inn of Court, and the Texas Young Lawyers Association.

Erin Flores Business Analyst, TMCx

After spending nearly a decade in academic research, Erin finally came to her senses and cut loose to join TMCx. Her background in biomedical science and genetics serves her well in the Innovation Institute—she tackles TMCx operational needs with the accuracy and precision of a multiplexed PCR protocol. She facilitates communications between TMCx companies and TMC member institutions and is determined to cultivate businesses with the greatest impact for patients and health care delivery in Houston.

In her free time Erin enjoys nurturing her own genetic experiment (her toddler Aveda), playing the ukulele, and reminiscing about her time wrangling cattle for her graduate research in bovine immunogenetics. Erin received her B.S. and Ph.D. from Texas A&M University and completed her postdoc at the University of Hawaii Cancer Center.

Frank Amini Business Analyst, TMCx

Frank Amini is an associate in Winstead's Intellectual Property Practice Group with substantial experience in patent prosecution. Frank has written and prosecuted numerous patent applications in various technological areas, including nanotechnology, oncology, gene expression, protein purification, stem cell biology, metabolism, small molecules,

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

drug delivery agents, energy storage devices, medical devices and mechanical devices. Prior to joining Winstead, Frank was a technical specialist at a Chicago law firm, where he assisted attorneys with the evaluation and management of various patent litigation cases in different technological areas, including pharmaceuticals, bio-therapeutics, medical devices, and mechanical devices. Frank also began his legal studies in Chicago. Prior to that, Frank worked on the development of a novel protein labeling method as a graduate student at the University of Texas Southwestern Medical Center in Dallas.

LauraLee Hughes, MBIOT

LauraLee Hughes serves as Executive Director for the Office of Technology Translation at the Texas A&M Health Science Center and currently leads efforts related technology commercialization, product development, entrepreneurship and innovation. Previously, LauraLee worked at the Texas A&M University System Office of Strategic Initiatives as a key technical and project manager for multiple research and development initiatives. Her major projects and responsibilities included the National Center for Therapeutics Manufacturing, the Defense Advanced Research Projects Agency (DARPA) Blue Angel Program, and most recently, the Texas A&M Center for Innovation in Advanced Development and Manufacturing. She has co-authored proposals that have resulted in over $380M in State and federal funding. LauraLee is a graduate of Texas A&M, where she earned her Bachelor of Science with a double major in Biochemistry and Genetics, a Master of Biotechnology, and a Graduate Certificate in Business. She currently serves on the Board of Directors for multiple early-stage TAMHSC startup companies and is a graduate of the Leadership Texas Class of 2014.

Jim Graham

Jim Graham is a biotechnology consultant based in Austin, Texas. Jim has over fifteen years of experience in life sciences finance, commercialization and entrepreneurship. He started his career in the West Coast office of Alex.Brown, the investment banking division of Deutsche Bank. Jim worked at Biogen Idec before moving to the Boston Office of McKinsey & Co. to join their Pharmaceutical and Medical Products practice. At McKinsey, Jim served leading pharmaceutical, biotechnology and medical device clients. Most recently, Jim was a principal at Sante Ventures, an early stage life sciences venture capital firm. Jim earned a B.S. in Biological Sciences with Honors from Stanford University, an S.M. in Biomedical Sciences from the Harvard-MIT Division of Health Sciences and Technology and an MBA from MIT Sloan. He also holds the Chartered Financial Analyst designation.

Joanne Mitchell

Joanne Mitchell, Ph.D. is a certified coach and speaker in the John Maxwell Team and coaches high performance women around the country on leadership, career development, career transition and business. She speaks on topics related to leadership and high performance. Joanne has a B.Sc. in Molecular Biology and Biochemistry from Durham University, U.K. and a Ph.D. in Biochemistry from Liverpool University, U.K.

Kala Marathi

Kala Marathi is the Executive Director of Innovation at the University of Houston's CT Bauer College of Business. In her role at UH, Kala is launching the Robinson Venture Fund and establishing other entrepreneurial-focused initiatives. Kala also served as Managing Director of the Houston Angel Network for 9 years. During this time, she has facilitated over $30M in investments in 85 early stage technology deals. She also helped create the Texas HALO Fund, the largest angel-focused sidecar fund in Texas. Kala has more than 15 years of operating and financial experience. Kala was formerly with Reliant Energy where she was a founding member of the corporate venture group, Reliant Energy Net Ventures. At Reliant, she led several smart grid pilots and technology initiatives, and launched a subsidiary called Texas Star Energy. She also has extensive experience in strategy and corporate finance with such firms as the Continental Airlines and Chase. Kala is a Director in the Texas Lyceum. She has also served on the Board of Directors of Texchange and the National Association of Women MBAs (Houston Chapter), as well as on the Advisory Board of the National Angel Education Foundation. Kala has B.A. in Japanese and Economics from Wellesley College, and an MBA from the Amos Tuck School of Business at Dartmouth College.

Paul Lammers, MD, MSc President & CEO, Mirna Therapeutics

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Paul Lammers, M.D., M.Sc., joined Mirna Therapeutics in November 2009 as its President, CEO, and Director of the Board. Since joining the company, Paul has led the team in successfully raising more than 150 million dollars for the company, both from leading traditional and corporate venture firms, Federal and State grant programs, including the Texas Emerging Technology Fund (ETF) and the Cancer Prevention and Research Institute of Texas (CPRIT), and by recently bringing the company public (NASDAQ: MIRN). Prior to joining Mirna Therapeutics, Dr. Lammers served as President of Repros Therapeutics in The Woodlands, Texas, after having served for 6 years as the Chief Medical Officer for EMD Serono Inc., a Division of German pharmaceutical company, Merck KgA. He began his career with Dutch pharmaceutical company, Organon, spending 8 years in the commercial and clinical operations in Europe and the US. He also served 4 years as Senior Vice President of clinical and regulatory affairs at Zonagen in The Woodlands, TX. Dr. Lammers obtained his Medical and Masters of Science degrees from Radboud University in Nijmegen, The Netherlands, and moved with his family to the US in 1992.

Larry Hope

Larry Hope joined MD Anderson Cancer Center's licensing office in January 2014 and more recently moved to the Strategic Industry Ventures group. His main role is to help "connect the dots" between industry needs and MD Anderson's capabilities. He focuses primarily on start-ups and creative collaborations. Previously, he was with CAP Resources, a boutique consulting firm in the energy and technology sectors and Baylor College of Medicine where he was responsible for all patenting and commercialization activities for the BCM departments of Orthopedic Surgery, Pediatrics, Biochemistry and Physical Medicine. Prior to Baylor, he held marketing / business development positions at several Houston-area biotechnology companies, the most recent being LifeCell Corporation. He has been a guest lecturer and panelist for a variety of technology and entrepreneurship-oriented programs and takes on advising roles as time permits. Larry holds a B.S. in Microbiology from Texas A&M University and an M.B.A. in Finance & Entrepreneurship from Rice University.

Mellie Price Managing Director, Capital Factory

Mellie Price, a 25 year Austinite, is the Executive Director of Technology Innovation at the Dell Medical School. She is an experienced investor, executive, fund manager and eight- time entrepreneur with a range of business experience from small private sector to a large publicly traded organization. She has created and managed both organic and explosive growth scenarios for variety of organizations.

Mellie is a founding mentor and Managing Director of Capital Factory as well as a General Partner to its investment fund. She is the co-founder of SoftMatch, which connects enterprises interested in innovation to the highly fragmented global startup ecosystem. Ms. Price was also the Founder & CEO of Austin’s own Front Gate Solutions and Front Gate Tickets, one of the largest privately held ticketing companies in the US/Canada from 2002 to 2015 when it was sold to Live Nation.

Ms. Price is an active member of the Texas entrepreneurship community and a winner of the prestigious Austin Business Journal’s 2015 Profiles in Power Award as well as the 2014 Tech Titan Award. She is a proud member of the Board of Directors for Leadership Austin and the Sustainable Food Center. She is also a founding Advisor to Texas Competes and currently serves on the Social Innovation Council and the Technology Advisory Committee for Austin Mayor Steve Adler.

Matt Cohen

Matt joined Osage University Partners in 2013 where he focuses on Life Science investments. He is a board observer at Spero Therapeutics, Faraday Pharma, and PMV Pharma. Prior to joining Osage, Matt was a strategy consultant with L.E.K. Consulting serving clients in biopharma, diagnostics, research tools, healthcare, and private equity. Engagements included strategy development, market assessment, commercialization support, portfolio development, acquisition target identification, and diligence / transaction support. As a Ph.D. student at the University of Pennsylvania, Matt conducted research on the antibody response to a novel protein-based poxvirus vaccine and advised several startups while working with the Penn Biotech Group.

Matt holds a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania, and a B.S. in Microbiology from the Pennsylvania State University.

Michael Lowe CEO, OrthoAccel Technologies

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Most recently, Mr. Lowe spent seven years at Philips Oral Healthcare (Royal Philips Electronics) where he worked in a variety of roles including global product management and brand management for Sonicare (Class I medical device, $350 million annual revenue). His experience comprises a range of marketing-related disciplines including dental professional sales management, sales training, promotion and advertising, market research, pricing strategy, and channel strategy development. While at Philips, he was nominated into the prestigious High Potential global management program, was listed as a co-inventor on a business application patent related to CRM, and developed a training program, Evidence-Based Dentistry, which won a regional MEDIC process improvement award for increased dental sales. He initially began working on the Sonicare business with Optiva, Inc. (1999 Inc. magazine Fastest Growing Privately Held Company award), joining Philips through the strategic acquisition process in 2000.

Mike Kuo

Mike Kuo is a Client Service Partner at Slalom Consulting, a provider of strategy, operations, change management and technology-enabled business transformation services. He leads key accounts and provides strategic leadership and direction for the healthcare practice, and is a Fellow of the American College of Healthcare Executives (FACHE).

Mike has extensive leadership experience in healthcare, previously serving as the Vice President of Commercial Operations at Cardinal Health, responsible for all support operations related to marketing, sales and product development in a $12B+ healthcare solutions and pharmaceutical supply chain enterprise. Prior to his tenure at Cardinal Health, Mike spent ten years at Pfizer in roles of increasing responsibility, with Director- level roles in Corporate Strategy, Global Business Analytics & Insights, Commercial Operations and Operational Excellence.

Mike spent five years at Deloitte, where he was part of the strategy and operations practice, focused in the Life Sciences industry. He holds an undergraduate degree from the Wharton School of the University of Pennsylvania and an MBA from Columbia Business School.

Nate Chang Director, Investment Banking – Global Biotech

Nate Chang is a Director of Credit Suisse in the Global Healthcare Investment Banking division based in San Francisco. Prior to rejoining Credit Suisse in 2013, Nate spent over 7 years at RBC Capital Markets and Morgan Stanley. Some of his public equity transaction experiences include the following: AbbVie: $14.7Bn notes offering, Affymax: $106MM IPO and $86MM common stock offering, Akebia: $115MM IPO, Amgen: €2.0Bn and CHF700MM notes offering, Amylin: $535MM common stock offering, Biogen: $6.0Bn notes offering, Corvus Pharmaceuticals: $78.0MM IPO Immunocore: $310.0MM private placement, Jazz Pharmaceuticals: $108MM IPO and $100MM credit facility in conjunction with the acquisition of EUSA, Neurocrine Biosciences: $142MM common stock offering, Portola: $172.5MM common stock offering; Prothena: $150MM initial public offering, $107MM common stock offering, PTC Therapeutics: $126MM and $125MM common stock offerings, Spark Therapeutics: $185MM initial public offering, ZS Pharma: $123MM initial public offering and $187MM common stock offering. Nate’s broader relevant healthcare experience includes clinical research (Quintiles / Gilead) and business development (PPD / J&J (Aiza)). Nate holds a BS in Molecular Biology from the University of California, San Diego and an MBA from the Tuck School of Business at Dartmouth.

Erin Flores Business Analyst, TMCx

Sam Razmandi

Sam has vast experience in financial reporting, budgetary controls and compliance,

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

internal controls, systems evaluation, automated systems implementation, and development and streamline of accounting department procedures. His consulting projects have included attorneys, architects, IT and public relations. Sam works with companies in the manufacturing, distribution, retail & wholesale, and professional services (attorneys, architects, public relations, IT). Sam enjoys working closely with owners and CFO’s to help them achieve their company goals by providing them reliable and timely financial information, improving processes and procedures, and helping them identify and understand key performance indicators.

Jacob Setterbo, Ph.D. Director of Grants, HIREtech

Dr. Jacob Setterbo is Director of Grants at HIREtech, where he helps life science companies obtain non-dilutive funding. Jacob focuses on small business grants (SBIR/STTRs) from the National Institutes of Health (NIH). He has provided consultation and technical writing for various therapeutic areas across the spectrum of NIH’s interests, including pharmaceuticals, medical devices, digital health, and health care delivery. Jacob assists with experimental design and commercialization components of each project. Jacob regularly vets early-stage companies with respect to innovation and commercial potential to determine their applicability for grants. As part of this process, Jacob evaluates business plans, market analyses, existing literature, patent portfolios, and Food and Drug Administration (FDA) meeting minutes. Jacob also assists with R&D Tax Credits at HIREtech. Jacob serves as an Advisor for the Texas Medical Center Accelerator (TMCx) and as an Advisory Board Member for the Terry Foundation. Jacob also served as a reviewer for the Texas Emerging Technology Fund and as a due diligence team member for the Houston Angel Network. Jacob received his Ph.D. in Biomedical Engineering from University of California, Davis and his B.S. in Civil Engineering from The University of Texas at Austin.

Cindy R. WalkerPeach, PhD

Dr. WalkerPeach joined the Austin Technology Incubator in early 2010 as lead advisor for healthcare-focused life sciences startups. She is responsible for critically evaluating new business ventures, managing a portfolio of bioscience startups and providing business mentoring to technology-focused entrepreneurs. She brings more than 20 years of experience in the biotechnology sector as a member of a number of startup teams, including Ambion Diagnostics and Asuragen. Her specialty areas include product development and technology assessment, business management/operations, corporate development and strategic product partnering, drug and companion diagnostic assay co- development, university and commercial collaborations, technology licensing and nucleic acid-based technologies. Dr. WalkerPeach completed a BS in Chemistry, PhD in Chemistry and Molecular Biology, focusing on understanding disease pathways and disease management strategies.

Srini Akkaraju, M.D., Ph.D. General Partner, Sofinnova Ventures

Srini has over 18 years of investment and operational experience in the Life Sciences sector. He joined Sofinnova in 2013 as a General Partner, and concentrates on biopharmaceutical investments. Srini’s board memberships have included Piramed (acquired by Roche), Eyetech Pharmaceuticals (EYET), Synageva BioPharma (GEVA), Seattle Genetics (SGEN), Intercept Pharmaceuticals, (ICPT), and Versartis.

Prior to joining Sofinnova, Srini was a Managing Director at New Leaf Venture Partners. Prior to NLVP, he was a co-founder and Managing Director at Panorama Capital. Before forming Panorama, he served as Partner of JP Morgan Partners. Prior to JP Morgan Partners, Srini held business and corporate development positions at Genentech.

Srini MD and PhD degrees in Immunology from Stanford University School of Medicine. He graduated with BA degrees in both Biochemistry and Computer Science from Rice University.

Stephen Curtis, Ph.D.

Stephen is responsible for sourcing, assessing, and leading bioscience investments for 2M Companies, the Dallas-based family office of Morton H. Meyerson. Steve also supports emerging companies in the 2M portfolio; he sits on the Boards of Partikula (mitochondria-targeting drug-delivery platform) and Therabracelet (wearable consumer/medical technology) and is an observer and interim manager for Odin Biotech (ophthalmology therapeutic). Prior to joining 2M, Steve ran the technology evaluation and in-licensing program at Reata Pharmaceuticals, a clinical-stage drug development company, leading cross-functional efforts to identify and acquire novel therapeutic programs across a variety of disease areas. Steve also interned at Siemens Venture

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Capital in Boston, analyzing markets of strategic interest.

Steve is a fellow in class 20 of the Kauffman Fellows Program, a competitive international fellowship program for high-potential innovation investors. He is also an advisor to the Health Wildcatters accelerator in Dallas and a member of the Oversight Committee for the Wallace H. Coulter Foundation’s Translational Partnership Program at University of Louisville.

Steve graduated summa cum laude from Cornell University, completing a dual BS degree in Molecular Biology and Applied Economics and Management, and earned his PhD in Biological and Biomedical Sciences at Harvard Medical School.

Tamsen Valoir, Ph.D.

Dr. Valoir focuses her practice on IP and FDA regulation in the life sciences, but she also has experience in copyright and trademark enforcement. Her work includes patent prosecution, infringement and patentability opinion work, licensing, due diligence, FDA patent term extensions and data exclusivities, as well as litigation related to copyright, trademark and patent infringement.

In addition to patent prosecution, Dr. Valoir’s practice has recently focused on IP and regulatory due diligence, clinical trial agreements, as well as various licensing agreements, including those to migrate IP to low tax jurisdictions. She has also done extensive work on freedom to operate (FTO) in several industries.

Dr. Valoir presented at Bio2009 on Global IP Due Diligence and Bio2010 on IP and Bankruptcy and has extensively published in the IP, tax, and regulatory areas.

Dr. Valoir has a Ph.D. in Biochemistry and Molecular Biology from Rice University and an LL.M. in Intellectual Property from the University of Houston.

Ann Tanabe CEO, BioHouston

Ann Tanabe was appointed CEO of BioHouston in October 2015 after serving four years as the company’s COO. Prior to joining BioHouston in 2011, Ann served as vice president of investor relations at Synthesis Energy Systems, a publicly traded alternative energy company from May 2008 to December 2010.

Prior to this position, Ann served as vice president of corporate communications and investor relations and investor relations director at Encysive Pharmaceuticals, a publicly traded biotechnology company from July 2003 to May 2008.

From October 2000 to July 2003, Ann served as investor relations manager and corporate communications coordinator to Texas Biotechnology, the predecessor company to Encysive Pharmaceuticals. Prior to 2000, Ann held a variety of positions at Rochem Separation Systems. Ann earned a BA degree from Loyola Marymount University.

Jeffrey Wade Executive VP, Corporate and Administrative Affairs , Lexicon Pharmaceuticals

Jeffrey L. Wade is executive vice president, corporate and administrative affairs and chief financial officer of Lexicon Pharmaceuticals, Inc., having previously served as the company’s general counsel and as senior vice president and chief financial officer. He has played an instrumental role in completing securities offerings for Lexicon totaling more than $1 billion; completing the acquisition of Coelacanth Corporation that established the basis for the company’s small molecule drug discovery efforts; and negotiating collaborations and licenses involving more than $775 million in committed funding to the company, including strategic alliances with Sanofi, Bristol-Myers Squibb, Genentech, Ipsen and Takeda, as well as a product financing collaboration with Symphony Capital. Before joining Lexicon, Mr. Wade was a partner with the law firm of Andrews & Kurth, where his practice consisted primarily of corporate finance and securities transactions, mergers and acquisitions, and partnerships and alliances. Mr. Wade received his B.A. (Plan II) and J.D. from The University of Texas.

William R. Buras

William brings over 29 years of diverse experience and demonstrated leadership in the biotechnology and healthcare industry to Texas. As Senior Director, William leads research development for Life Sciences Division of Tietronix. William serves as Chair of the Industrial Advisory Board for the National Science Foundation “Cyber-Operating Room” center of excellence and is the Principal Investigator for medical research projects funded by the National Institutes of Health, The Defense Health Program and NASA’s Johnson Space Center. Prior to these roles, William served a variety of technical and scientific leadership roles at DuPont, Eli Lilly and Cyberonics where he has managed programs of scientific research consisting of as many as 200+ individual clinical/pre-

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

clinical/engineering studies. In addition to 8 patented and licensed medical devices, William led and published results of the first controlled study demonstrating the clinical benefits of adding an atypical antipsychotic to SSRI’s for treating Resistant Depression.

Angela Shah

Angela Shah is the editor of Xconomy Texas. She has written about startups along a wide entrepreneurial spectrum, from Silicon Valley transplants to Austin partying in the '90s tech boom to 20-something women defying cultural norms as they seek to build vital IT infrastructure in a war-torn Afghanistan. As a foreign correspondent based in Dubai, her work appeared in The New York Times, TIME, Newsweek/Daily Beast and Forbes Asia.

Before moving overseas, Shah was a staff writer and columnist with The Dallas Morning News and the Austin American-Statesman. She has an MBA from Tulane University, a Bachelor's of Journalism from the University of Texas at Austin and is a 2007 Knight- Wallace Fellow at the University of Michigan.

David Parkinson

Dr. Parkinson has served as a director of the Company since June 24, 2015 and has been employed full time as the President and Chief Executive Officer of the Company since January 7, 2016. He is responsible for the management of the Company, developing objectives, strategy and standards of performance, securing and leading a team of professionals and directing them to deliver the required performance. Most recently Dr. Parkinson has served as a venture partner at New Enterprise Associates (NEA), Inc., and following his assumption of these new Essa-related responsibilities he has moved to the role of venture advisor to NEA. From 2007 until 2012, Dr. Parkinson served as President and CEO of Nodality, a biotechnology company focused on the biological characterization of signaling pathways in patients with malignancy to enable more effective therapeutics development and clinical decision-making. Dr. Parkinson has previously led oncology clinical development activities at Novartis (1997-2003), Amgen (2003-2006) and Biogen Idec 2006-2007). He worked at the National Cancer Institute from 1990 to 1997, serving as Chief of the Investigational Drug Branch, and then as Acting Associate Director of the Cancer Therapy Evaluation Program (CTEP). Dr. Parkinson is a past Chairman of the Food & Drug Administration (FDA) Biologics Advisory Committee, has also served on the FDA’s Science Board, and is a recipient of the FDA's Cody Medal. He has served on the National Cancer Policy Forum of the Institute of Medicine, as a board director for the Ontario Institute for Cancer Research, and is a past co-chair of the Cancer Steering Committee of the NIH Foundation Biomarkers Consortium. He currently serves as a Board Director for the Multiple Myeloma Research Foundation and has served as Chairperson of the American Association of Cancer Research (AACR) Finance and Audit Committee for the last 15 years. Dr. Parkinson was formerly a Director of Facet Biotech, Inc. and Ambit Biosciences, both public biopharma companies which were acquired by large pharma. He currently serves as Director on the Boards of Cerulean Pharma Inc., 3S Bio Inc. He has held academic positions both at Tufts and at the University of Texas MD Anderson Cancer Center, and has authored over 100 peer-reviewed publications.

John Demarco, JD

John Demarco is a United States patent attorney and partner in the IP Group of Haynes and Boone LLP in Houston. He focuses on patent and trademark counseling, licensing, litigation, and prosecution. He helps companies design around patents, defend against patent assertions, enforce/license intellectual property, resolve complex patent prosecution issues, and acquire and develop technology and intellectual property. John's technical experience includes: medical devices and imaging (fluorescence, MRI, CT, and OCT); pharmaceuticals; software; and digital reading, storage, display, printing and camera devices.

Mini Kapoor, PhD, JD

Mini is a scientist and a lawyer. Prior to her career in law, she was a faculty at MD Anderson Cancer Center, Houston, Texas. Mini's research focus was development of genomics technologies for high-throughput patient sample profiling. Currently, Mini is a practicing lawyer at Haynes and Boone, LLP, and a registered attorney at the United States Patent and Trademark Office. Her practice areas include intellectual property matters, including patents, trade secrets and trademarks. Mini's experience includes patent opinions, technology licensing, and litigation. She is also experienced in general commercial business matters and has represented large, mid-size and small entities in contract disputes as well as intellectual property matters.

Quick Facts Recent Speakers Company Spotlight Earned Excellence

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] Speakers - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Since inception in 2000, the Rice Alliance has assisted in the launch of more than 250 new technology companies, which have raised more than half a billion dollars in early-stage funding

http://alliance.rice.edu/2016_txlsvf_speakers/[12/15/2016 10:42:40 AM] 2016 Texas Life Science Venture Forum - Past Investors : Rice Alliance for Technology and Entrepreneurship - Rice University

Past Investors 2016 Texas Life Science Forum Thursday, May 26, 2016 8:00 am - 6:30 pm BioScience Research Collaborative (BRC) 6500 Main Street Houston, Texas 77030 (713) 632-4130

Agenda Speakers

Presenting Past Investors Companies Sponsorship FAQs Opportunities

Testimonials Hotels

Presenting Sponsor

Gold Underwriters

One on One Meeting Sponsors

Welcome Reception Sponsor

Networking Reception and Company Showcase Sponsor

Company Presentation Sponsor

http://alliance.rice.edu/2016_txlsvf_past_investors/[12/15/2016 10:43:47 AM] 2016 Texas Life Science Venture Forum - Past Investors : Rice Alliance for Technology and Entrepreneurship - Rice University

General Sponsors

Exhibiting Sponsors

Supporting Sponsors

Venture Patrons

Quick Facts Recent Speakers Company Spotlight Earned Excellence

E&Y Entrepreneur of the Year – Award for Supporter of Entrepreneurship – 2005

http://alliance.rice.edu/2016_txlsvf_past_investors/[12/15/2016 10:43:47 AM] Sponsorship Opportunities - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Sponsorship Opportunities 2016 Texas Life Science Forum If you are interested in sponsoring this year’s Texas Life Science Forum, please contact Ann Tanabe from BioHouston Thursday, May 26, 2016 at [email protected] or Brad Burke at the Rice Alliance at [email protected]. 8:00 am - 6:30 pm BioScience Research Collaborative (BRC) 6500 Main Street Houston, Texas 77030 (713) 632-4130

Agenda Speakers

Presenting Past Investors Companies Sponsorship FAQs Opportunities

Testimonials Hotels

Presenting Sponsor

Gold Underwriters

One on One Meeting Sponsors

Welcome Reception Sponsor

Networking Reception and Company Showcase Sponsor

Company Presentation Sponsor

http://alliance.rice.edu/2016_txlsvf_sponsorship/[12/15/2016 10:44:43 AM] Sponsorship Opportunities - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

General Sponsors

Exhibiting Sponsors

Supporting Sponsors

Venture Patrons

Quick Facts Recent Speakers Company Spotlight Earned Excellence

The most recent Rice Alliance Company Directory included more than 500 companies, the largest ever collection of new technology companies in the region

http://alliance.rice.edu/2016_txlsvf_sponsorship/[12/15/2016 10:44:43 AM] Hotels - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Hotels 2016 Texas Life Science Forum Hilton Houston Plaza/Medical Center – Conference Hotel Thursday, May 26, 2016 6633 Travis St, Houston, TX 77030 8:00 am - 6:30 pm

BioScience Research Collaborative (BRC) Discount reservations can be made by clicking on the link below or calling our 24 Hour Central Reservations 6500 Main Street Department at 1-800-HILTONS (1-800-445-8667) asking for the Group Code: LSV or ask for the group by name Life Houston, Texas 77030 Science Venture Forum 2016 when making their reservation. (713) 632-4130

The cut-off date for guests to make reservations online is 05/13/2016 at 5pm. After 5/13/2016, you will need to call the hotel directly in order to obtain the group discount.

Booking Link: http://group.hilton.com/LifeScienceVentureForum2016

Group Name: Life Science Venture Forum 2016 Agenda Speakers

Arrival Date: 23-May-2016 Presenting Past Investors Departure Date: 27-May-2016 Companies

Sponsorship Other Hotels in the Area FAQs Opportunities

Hotel Zaza: Testimonials Hotels 5701 Main St., Houston

Best Western Plaza Hotel: 6700 Main St., Houston Texas

Wyndham Hotel Presenting Sponsor 6800 Main St., Houston, Texas

Gold Underwriters

One on One Meeting Sponsors

Welcome Reception Sponsor

Networking Reception and Company Showcase Sponsor

Company Presentation Sponsor

http://alliance.rice.edu/2016_txlsvf_hotels/[12/15/2016 10:45:31 AM] Hotels - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

General Sponsors

Exhibiting Sponsors

Supporting Sponsors

Venture Patrons

http://alliance.rice.edu/2016_txlsvf_hotels/[12/15/2016 10:45:31 AM] Hotels - 2016 Texas Life Science Venture Forum : Rice Alliance for Technology and Entrepreneurship - Rice University

Quick Facts Recent Speakers Company Spotlight Earned Excellence

More than 120 past teams have launched their companies and are in business today having raised more than $337 million in funding.

http://alliance.rice.edu/2016_txlsvf_hotels/[12/15/2016 10:45:31 AM]